BR112016001316B1 - Método de formação de imagem útil no diagnóstico dedoença neurológica, meio de armazenamento de memória, e, uso de um meio de armazenamento de memória - Google Patents

Método de formação de imagem útil no diagnóstico dedoença neurológica, meio de armazenamento de memória, e, uso de um meio de armazenamento de memória Download PDF

Info

Publication number
BR112016001316B1
BR112016001316B1 BR112016001316-6A BR112016001316A BR112016001316B1 BR 112016001316 B1 BR112016001316 B1 BR 112016001316B1 BR 112016001316 A BR112016001316 A BR 112016001316A BR 112016001316 B1 BR112016001316 B1 BR 112016001316B1
Authority
BR
Brazil
Prior art keywords
normal
imaging
radiopharmaceutical
individual
memory storage
Prior art date
Application number
BR112016001316-6A
Other languages
English (en)
Portuguese (pt)
Inventor
Mark Joseph Rosser
Jan Wolber
Original Assignee
Ge Healthcare Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ge Healthcare Limited filed Critical Ge Healthcare Limited
Publication of BR112016001316B1 publication Critical patent/BR112016001316B1/pt

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/48—Diagnostic techniques
    • A61B6/481—Diagnostic techniques involving the use of contrast agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/02—Arrangements for diagnosis sequentially in different planes; Stereoscopic radiation diagnosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/50—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications
    • A61B6/501—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications for diagnosis of the head, e.g. neuroimaging or craniography
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/52—Devices using data or image processing specially adapted for radiation diagnosis
    • A61B6/5211—Devices using data or image processing specially adapted for radiation diagnosis involving processing of medical diagnostic data
    • A61B6/5217—Devices using data or image processing specially adapted for radiation diagnosis involving processing of medical diagnostic data extracting a diagnostic or physiological parameter from medical diagnostic data
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Optics & Photonics (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Biophysics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Physiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Dentistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nuclear Medicine (AREA)
  • Pulmonology (AREA)
  • Theoretical Computer Science (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Primary Health Care (AREA)
BR112016001316-6A 2013-07-25 2014-07-25 Método de formação de imagem útil no diagnóstico dedoença neurológica, meio de armazenamento de memória, e, uso de um meio de armazenamento de memória BR112016001316B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1313291.5A GB201313291D0 (en) 2013-07-25 2013-07-25 Imaging neurological disease
GB1313291.5 2013-07-25
PCT/EP2014/066042 WO2015011267A1 (en) 2013-07-25 2014-07-25 Imaging neurological disease

Publications (1)

Publication Number Publication Date
BR112016001316B1 true BR112016001316B1 (pt) 2021-04-06

Family

ID=49166921

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112016001316-6A BR112016001316B1 (pt) 2013-07-25 2014-07-25 Método de formação de imagem útil no diagnóstico dedoença neurológica, meio de armazenamento de memória, e, uso de um meio de armazenamento de memória

Country Status (16)

Country Link
US (1) US11051777B2 (cg-RX-API-DMAC7.html)
EP (1) EP3024501B1 (cg-RX-API-DMAC7.html)
JP (1) JP6590801B2 (cg-RX-API-DMAC7.html)
KR (1) KR102340504B1 (cg-RX-API-DMAC7.html)
CN (1) CN105392500B (cg-RX-API-DMAC7.html)
AU (2) AU2014294983B2 (cg-RX-API-DMAC7.html)
BR (1) BR112016001316B1 (cg-RX-API-DMAC7.html)
CA (1) CA2916125A1 (cg-RX-API-DMAC7.html)
DK (1) DK3024501T3 (cg-RX-API-DMAC7.html)
ES (1) ES2722973T3 (cg-RX-API-DMAC7.html)
GB (1) GB201313291D0 (cg-RX-API-DMAC7.html)
IL (1) IL243383B (cg-RX-API-DMAC7.html)
MX (1) MX2016001012A (cg-RX-API-DMAC7.html)
RU (1) RU2015155792A (cg-RX-API-DMAC7.html)
SG (1) SG11201600571RA (cg-RX-API-DMAC7.html)
WO (1) WO2015011267A1 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104720840A (zh) * 2015-02-11 2015-06-24 清华大学深圳研究生院 基于多巴胺转运体显像特异性摄取比的半自动量化方法
TWI587841B (zh) * 2015-03-06 2017-06-21 國立陽明大學 定量分析核子醫學腦部影像的系統及方法
WO2016152448A1 (ja) * 2015-03-24 2016-09-29 日本メジフィジックス株式会社 画像処理装置、画像処理方法、及びプログラム
KR101720288B1 (ko) 2016-05-11 2017-03-28 (주)바이오액츠 뇌 영상용 염료 및 이의 제조방법
JP6549521B2 (ja) * 2016-05-25 2019-07-24 富士フイルム富山化学株式会社 疾患鑑別支援装置及びコンピュータプログラム
TWI607739B (zh) * 2016-05-27 2017-12-11 許百靈 Spect多巴胺顯像定量分析技術與在腦多巴胺評估的用途
GB201621698D0 (en) * 2016-12-20 2017-02-01 Ge Healthcare Ltd (Ip) And Stichting Vumc And Acad Medical Center Differential Diagnosis
JP6995642B2 (ja) * 2018-01-19 2022-01-14 日本メジフィジックス株式会社 画像処理装置、画像処理方法およびプログラム
TWI686178B (zh) 2019-10-09 2020-03-01 中原大學 自動化定位核子醫學腦部影像紋狀體與計算紋狀體專一性攝取率的方法與系統
US20230001026A1 (en) * 2019-11-21 2023-01-05 Likeminds, Inc. Pharmaceutical packaging units and methods for concomitant administration of radiotracers
PE20240822A1 (es) 2021-03-22 2024-04-18 Neurocrine Biosciences Inc Inhibidores de vmat2 y metodos de uso
JP7834281B2 (ja) * 2022-02-18 2026-03-24 社会福祉法人兵庫県社会福祉事業団 画像処理プログラム、画像処理方法、および画像処理装置
CN119599879B (zh) * 2024-11-06 2025-10-24 复旦大学附属华山医院 一种基于深度学习的pet图像跨膜态合成方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010540512A (ja) * 2007-09-26 2010-12-24 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ 異なるタイプの認知症を特異的に診断する方法
US8084018B2 (en) * 2007-10-31 2011-12-27 Alseres Pharmaceuticals, Inc. Methods for imaging dopamine transporter level
EP2211911A4 (en) * 2007-10-31 2012-11-14 Alseres Pharmaceuticals Inc METHOD FOR DIAGNOSIS AND MONITORING OF THE TREATMENT OF LEWY BODILY DAMAGE BY EVALUATING THE DOPAMIN TRANSPORTER MIRROR

Also Published As

Publication number Publication date
EP3024501B1 (en) 2019-03-27
IL243383B (en) 2018-07-31
RU2015155792A3 (cg-RX-API-DMAC7.html) 2018-05-23
AU2014294983A1 (en) 2016-01-21
CN105392500B (zh) 2023-08-18
WO2015011267A1 (en) 2015-01-29
MX2016001012A (es) 2016-05-09
JP6590801B2 (ja) 2019-10-16
GB201313291D0 (en) 2013-09-11
EP3024501A1 (en) 2016-06-01
KR102340504B1 (ko) 2021-12-20
US11051777B2 (en) 2021-07-06
SG11201600571RA (en) 2016-02-26
KR20160037168A (ko) 2016-04-05
AU2019253837B2 (en) 2021-11-25
US20160183897A1 (en) 2016-06-30
ES2722973T3 (es) 2019-08-20
CA2916125A1 (en) 2015-01-29
JP2016531903A (ja) 2016-10-13
DK3024501T3 (da) 2019-05-06
HK1222118A1 (zh) 2017-06-23
CN105392500A (zh) 2016-03-09
RU2015155792A (ru) 2017-08-30
AU2014294983B2 (en) 2019-10-24
AU2019253837A1 (en) 2019-11-14

Similar Documents

Publication Publication Date Title
AU2019253837B2 (en) Imaging neurological disease
Politis et al. Positron emission tomography imaging in neurological disorders
Zhu et al. PET/SPECT imaging agents for neurodegenerative diseases
Hickey et al. Diagnostic imaging of Alzheimer's disease with copper and technetium complexes
JP5603855B2 (ja) 神経変成疾患の放射性薬剤による画像化
Maddahi Properties of an ideal PET perfusion tracer: new PET tracer cases and data
Masterman et al. Sensitivity, specificity, and positive predictive value of technetium 99-HMPAO SPECT in discriminating Alzheimer's disease from other dementias
Hsiao et al. Comparison of 99mTc-TRODAT-1 SPECT and 18 F-AV-133 PET imaging in healthy controls and Parkinson’s disease patients
JP2011502966A5 (cg-RX-API-DMAC7.html)
JP2011502130A (ja) ドーパミン輸送体レベルを造影するための方法
JP2010540512A (ja) 異なるタイプの認知症を特異的に診断する方法
Kurtys et al. Evaluating [11C] PBR28 PET for monitoring gut and brain inflammation in a rat model of chemically induced colitis
Booij et al. Imaging of striatal dopamine transporters in rat brain with single pinhole SPECT and co-aligned MRI is highly reproducible
Pain et al. Human biodistribution and internal dosimetry of 4-[18 F] fluorobenzyl-dexetimide: a PET radiopharmaceutical for imaging muscarinic acetylcholine receptors in the brain and heart
Edison et al. Strategies for the generation of parametric images of [11C] PIB with plasma input functions considering discriminations and reproducibility
Huang et al. Chronic manganism: a long-term follow-up study with a new dopamine terminal biomarker of 18F-FP-(+)-DTBZ (18F-AV-133) brain PET scan
Kreimerman et al. Biological Assessment of a 18F-Labeled Sulforhodamine 101 in a Mouse Model of Alzheimer’s Disease as a Potential Astrocytosis Marker
WO2019023815A1 (es) Nuevos compuestos derivados de piridinmetilsulfinilbenzoxazoles y piridinmetilsulfinibenzotiazoles, marcados radiactivamente o con fluorescencia y sus composiciones, como biomarcadores especificos para el diagnostico de enfermedades neurodegenerativas y patologías involucradas con la proteína tau
He Detecting and quantifying c-fos in vivo by PET imaging of DREADD-expressing neurons in mice brains after sleep deprivation
Holman et al. SPECT Imaging in Alzheimer's Disease
Scherfler et al. Topography of cerebral monoamine transporter availability in families with SCA2 mutations: a voxel-wise [123I] β-CIT SPECT analysis
RU2692451C2 (ru) Способ радионуклидной диагностики опухолей головного мозга
HK1222118B (en) Imaging neurological disease
RU2629044C1 (ru) Способ количественного определения накопления радиофармпрепарата при радионуклидном исследовании перфузии легких
Lucignani Amyloid imaging with PET: methodological issues and correlative studies

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 25/07/2014, OBSERVADAS AS CONDICOES LEGAIS.